are glp-1 patches safe and effective How to Wear Patches: Current Status Approved Alternatives Do GLP-1 Patches Really Work?

Research indicates many patients regain some weight after discontinuing treatment, which is why a long-term maintenance plan matters

Novo in December 2025 nevertheless pushed through with an FDA filing for CagriSema as a weight-loss medicine, proposing weekly use in patients with obesity or who are overweight with at least one related comorbidity

The pharma companys injectable GLP-1/GIP receptor agonist CT-388 is an important element of its weight loss strategy and also delivered benefits for pre-diabetic patients

Consistent with prior studies 4,24 , ACLY KO cells maintain lower levels of histone acetylation at H3K23 and H3K14 than their WT and ACSS2 KO counterparts, and DKO cells exhibit similar levels of acetylation as single ACLY KO cells (Figure 4A, B)